Brad Ringeisen

Company: Innovative Genomics Initiative

Job title: Executive Director

Seminars:

Panel Discussion: Driving Collaborations to Unlock New Therapeutic Opportunities 8:00 am

Evaluate partnerships between pharma and biotech companies and the impact academia can have on the development of genome editing therapies Discuss the ideal criteria for company collaborations and investment to improve discovery efficiency Highlight key strategies from successful collaborations to direct and refine future collaborative effortsRead more

day: Day Two

The Future: How Baby KJ’s Personalized CRISPR Therapy Will Facilitate Better Rare Disease Targeting 9:35 am

Following the groundbreaking work to launch the world’s first personalized CRISPR therapy to treat baby KJ, a new blueprint for rare disease treatment is forming. With the baby KJ team swiftly adapting base editing technology, rapidly co-ordinating regulatory approval and redefining clinical strategies, this session offers an unmissable insight into how this pioneering approach to…Read more

day: Pre-Conference Workshop Day